Interact to see
Advertisement
Advertisement
CURE vs SPXL
CURE vs SPXL Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
CURE vs. SPXL commentary
Oct 19, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a Hold and SPXL is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 5.51B vs. CURE (185M). SPXL has a higher annual dividend yield than CURE: SPXL (24.556) vs CURE (-1.147). CURE was incepted earlier than SPXL: CURE (14 years) vs SPXL (17 years). SPXL (0.87) has a lower expense ratio than CURE (0.93). SPXL has a higher turnover CURE (23.00) vs CURE (23.00).
| CURE | SPXL | CURE / SPXL | |
| Gain YTD | -1.147 | 24.556 | -5% |
| Net Assets | 185M | 5.51B | 3% |
| Total Expense Ratio | 0.93 | 0.87 | 107% |
| Turnover | 23.00 | 29.00 | 79% |
| Yield | 1.29 | 0.79 | 164% |
| Fund Existence | 14 years | 17 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SPXL | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 87% | 3 days ago 90% |
| Momentum ODDS (%) | 3 days ago 88% | 3 days ago 84% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 84% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| TrendMonth ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Advances ODDS (%) | 5 days ago 90% | 18 days ago 90% |
| Declines ODDS (%) | 7 days ago 90% | 10 days ago 89% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| Aroon ODDS (%) | 3 days ago 90% | 3 days ago 90% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| LYFCX | 14.17 | 0.09 | +0.64% |
| AlphaCentric Life Sciences & Hlthcare C | |||
| PEIJX | 42.47 | 0.13 | +0.31% |
| Principal Equity Income J | |||
| IBARX | 26.04 | 0.07 | +0.27% |
| Macquarie Balanced Fund Class R6 | |||
| NWZMX | 22.57 | 0.01 | +0.04% |
| Nationwide Loomis All Cap Gr R6 | |||
| TEMUX | 17.30 | -0.03 | -0.17% |
| Morgan Stanley Pathway Em Mkts Eq | |||
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been closely correlated with TMO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then TMO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +1.89% | ||
| TMO - CURE | 71% Closely correlated | +0.40% | ||
| DHR - CURE | 67% Closely correlated | -0.88% | ||
| MTD - CURE | 67% Closely correlated | -0.76% | ||
| A - CURE | 67% Closely correlated | +0.58% | ||
| PFE - CURE | 67% Closely correlated | +1.16% | ||
More | ||||
SPXL and
Correlation & Price change
A.I.dvisor indicates that over the last year, SPXL has been loosely correlated with MSFT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPXL jumps, then MSFT could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To SPXL | 1D Price Change % | ||
|---|---|---|---|---|
| SPXL | 100% | +1.60% | ||
| MSFT - SPXL | 63% Loosely correlated | +0.39% | ||
| AAPL - SPXL | 62% Loosely correlated | +1.96% | ||
| AMZN - SPXL | 60% Loosely correlated | -0.67% | ||
| META - SPXL | 59% Loosely correlated | +0.68% | ||
| NVDA - SPXL | 56% Loosely correlated | +0.78% | ||
More | ||||